electrophoret
mobil
shift
assay
nuclear
protein
extract
cell
line
describ
elsewher
extract
nuclear
protein
cell
perform
h
treatment
uml
r
f
system
probe
use
electrophoret
mobil
shift
assay
emsa
prepar
denatur
complementari
singlestrand
oligonucleotid
figur
min
follow
cool
room
temperatur
probe
radiolabel
atp
cimmol
mciml
perkin
elmer
use
polynucleotid
kinas
promega
follow
purif
use
microspin
column
ge
healthcar
life
scienc
emsa
reaction
perform
use
gel
shift
bind
buffer
promega
accord
manufactur
protocol
brief
reaction
contain
cell
nuclear
protein
extract
label
probe
variou
concentr
unlabel
probe
appropri
incub
room
temperatur
min
bovin
serum
albumin
use
place
cell
nuclear
protein
extract
neg
control
reaction
mixtur
underw
electrophoresi
polyacrylamid
gel
acrylamidebisacrylamid
tbe
electrophoresi
gel
vacuumdri
radioact
signal
detect
expos
dri
gel
xray
film
overnight
intens
upshift
band
quantit
measur
densitomet
emsa
duplic
snp
experiment
set
sar
patient
control
subject
subject
recruit
studi
describ
elsewher
approv
respect
institut
review
board
hospit
involv
written
inform
consent
obtain
sar
patient
donat
peripher
blood
control
subject
donat
saliva
total
chines
sar
patient
recruit
either
outbreak
sar
followup
outpati
clinic
hospit
hong
kong
name
pamela
youd
nethersol
hospit
princess
margaret
hospit
unit
christian
hospit
queen
mari
hospit
alic
ho
miu
ling
nethersol
hospit
princ
wale
hospit
sar
patient
confirm
seroposit
clinic
data
retrospect
obtain
hospit
author
hong
kong
permiss
attend
clinician
respect
hospit
household
contact
control
subject
member
household
sar
patient
remain
unaffect
seroneg
end
outbreak
recruit
household
contact
control
subject
ask
state
relationship
sar
patient
famili
member
household
addit
control
subject
describ
elsewher
control
sampl
collect
result
total
control
subject
genom
dna
peripher
blood
sampl
extract
use
convent
method
level
biosafeti
precaut
accord
world
health
organ
center
diseas
control
guidelin
household
contact
control
subject
donat
saliva
sampl
extract
buccal
dna
oragen
dna
selfcollect
kit
dna
genotek
demograph
characterist
featur
clinic
profil
sar
patient
household
contact
control
subject
success
genotyp
summar
tabl
genotyp
two
mxa
promot
snp
ncbi
studi
genotyp
subject
perform
polymeras
chain
reaction
pcr
restrict
fragment
length
polymorph
describ
except
use
differ
revers
primer
describ
forward
primer
use
revers
primer
design
us
pcr
use
amplitaq
gold
dna
polymeras
appli
biosystem
accord
manufactur
instruct
follow
thermal
cycl
condit
initi
denatur
min
subsequ
cycl
follow
final
extens
min
pcr
product
digest
either
u
hhai
u
psti
ge
healthcar
digest
product
analyz
agaros
gel
figur
size
undigest
product
major
allel
creat
hhai
restrict
site
gcgc
cleav
fragment
bp
bp
wherea
minor
allel
resist
hhai
restrict
major
allel
creat
psti
site
ctgcag
cleav
fragment
bp
bp
wherea
minor
allel
abolish
psti
restrict
site
ten
percent
sampl
duplic
confirm
genotyp
data
control
sampl
known
homozyg
heterozyg
genotyp
notempl
control
includ
run
pcr
restrict
fragment
length
polymorph
call
genotyp
basi
electrophoresi
blindli
check
individu
research
independ
genet
risk
associ
analys
genotyp
allel
distribut
patient
group
control
group
assess
test
use
spss
window
softwar
version
spss
inc
logist
regress
use
stata
window
softwar
version
statacorp
lp
applic
odd
ratio
or
confid
interv
ci
use
measur
strength
associ
hardyweinberg
equilibrium
assess
test
p
consid
signific
valu
haplotyp
frequenc
calcul
haploview
softwar
version
dali
lab
portion
patient
control
subject
came
household
logist
regress
analysi
robust
cluster
method
perform
factor
effect
genet
relat
subject
confound
risk
associ
subject
cluster
accord
genet
relationship
sampl
subset
contain
genet
unrel
subject
also
gener
analysi
logist
regress
also
perform
adjust
age
sex
subject
statu
patient
control
subject
use
depend
variabl
genotyp
either
one
snp
age
sex
use
independ
variabl
bonferroni
adjust
appli
adjust
level
signific
multipl
test
ordinari
level
signific
adjust
n
n
n
number
snp
analyz
analysi
associ
clinic
outcom
measur
twentythre
clinic
outcom
measur
analyz
tabl
associ
snp
binomi
clinic
outcom
measur
analyz
use
test
describ
elsewher
numer
variabl
analyz
use
analysi
varianc
spss
softwar
version
electrophoret
mobil
shift
assay
emsa
use
investig
bind
affin
nuclear
protein
probe
bear
snp
figur
express
mxa
cell
report
elsewher
also
confirm
reversetranscript
pcr
rtpcr
studi
figur
use
quantit
pcr
qpcr
also
show
induct
mxa
mrna
treatment
figur
investig
differ
respons
treatment
emsa
perform
use
nuclearprotein
extract
cell
either
untreat
treat
nuclearprotein
extract
emsa
nuclear
extract
untreat
cell
mxa
probe
bound
cell
nuclear
protein
result
upshift
band
lane
figur
compar
lane
nuclear
protein
lane
figur
bind
nuclear
protein
hot
probe
compet
cold
unlabel
probe
allel
separ
reaction
upshift
band
hot
probe
lane
significantli
diminish
intens
competit
cold
probe
wherea
competit
cold
probe
decreas
band
intens
lane
dosagedepend
manner
consist
upshift
band
intens
hot
probe
diminish
competit
cold
probe
lane
competit
cold
probe
lane
stronger
band
intens
indic
stronger
bind
find
suggest
bind
affin
nuclear
protein
allel
slightli
stronger
allel
nevertheless
decreas
band
intens
competit
either
cold
probe
weak
indic
bind
protein
probe
specif
strong
mxa
probe
also
bound
cell
nuclear
protein
result
upshift
band
lane
figur
band
intens
upshift
probe
lane
obvious
stronger
probe
lane
indic
bind
affin
nuclear
protein
stronger
upshift
band
hot
almost
complet
elimin
competit
cold
probe
lane
cold
probe
lane
hand
intens
upshift
hot
probe
could
diminish
cold
probe
lane
much
less
effect
cold
probe
lane
emsa
nuclear
extract
ifn
b
treat
cell
although
differ
bind
affin
nuclear
protein
probe
weak
interferonstimul
respons
element
snp
resid
suggest
snp
may
affect
bind
affin
nuclear
protein
extract
cell
bind
strongli
emsa
thu
repeat
use
nuclear
protein
extract
cell
figur
predict
upshift
band
strong
intens
observ
hot
probe
lane
could
compet
away
cold
probe
dosagedepend
manner
lane
howev
strong
intens
shift
band
observ
hot
probe
lane
howev
emsa
use
nuclear
protein
cell
show
similar
pattern
untreat
cell
ie
upshift
band
obvious
stronger
lane
figur
e
band
could
compet
correspond
cold
probe
dosagedepend
manner
lane
lane
find
suggest
preferenti
bind
nuclear
protein
allel
enhanc
stimul
bind
snp
irrespect
treatment
genotyp
analys
mxa
snp
emsa
result
suggest
mxa
snp
may
differ
effect
relat
ifnmedi
immun
respons
known
import
factor
pathogenesi
sar
vivo
evid
support
vitro
observ
genet
associ
studi
perform
subject
recruit
subject
patient
control
subject
success
genotyp
snp
snp
hardyweinberg
equilibrium
patient
control
subject
p
subject
patient
control
subject
genet
unrel
tabl
logist
regress
perform
robust
cluster
method
genotyp
data
subject
factor
impact
genet
relationship
subject
result
show
genotyp
significantli
associ
decreas
suscept
sar
coronaviru
infect
p
ci
p
ci
respect
stronger
associ
clearli
demonstr
snp
tabl
analysi
genet
unrel
subject
also
show
significantli
decreas
risk
similar
sar
coronaviru
infect
genotyp
p
ci
allel
p
ci
well
genotyp
p
ci
allel
p
ci
stronger
associ
demonstr
snp
tabl
exclud
confound
effect
age
sex
logist
regress
analysi
adjust
age
sex
perform
result
confirm
signific
associ
remain
valid
snp
wherea
snp
becam
margin
signific
tabl
previou
report
suggest
snp
synthetas
g
g
snp
associ
risk
sar
coronaviru
infect
genotyp
snp
howev
show
associ
see
appendix
avail
print
edit
journal
tabl
explor
possibl
confound
effect
snp
may
confer
risk
associ
mxa
snp
logist
regress
adjust
snp
togeth
age
sex
perform
tabl
although
snp
significantli
affect
associ
snp
p
render
associ
snp
insignific
p
compar
adjust
signific
cutoff
bonferroni
adjust
n
linkag
disequilibrium
mxa
snp
snp
valu
subject
unrel
subject
wherea
r
respect
indic
snp
perfect
ld
haplotyp
frequenc
analysi
patient
control
subject
tabl
show
respect
wildtyp
haplotyp
haplotyp
ie
associ
lower
risk
sar
p
ci
tabl
analysi
associ
clinic
outcom
check
whether
snp
might
influenc
clinic
outcom
genotyp
analyz
clinic
outcom
measur
possibl
associ
prognosi
sar
analys
assist
ventil
outcom
measur
show
signific
associ
snp
data
shown
emsa
data
show
snp
preferenti
bind
minor
allel
enhanc
stimul
consist
allel
similar
consensu
interferonstimul
respons
element
snp
preferenti
bind
minor
allel
irrespect
treatment
result
consist
previou
luciferas
find
greater
increas
promot
activ
seen
treatment
allel
signific
effect
snp
wherea
allel
contribut
increas
promot
activ
absenc
treatment
data
suggest
absenc
ifn
induct
snp
may
greater
effect
basal
mxa
level
snp
induct
ifn
report
suppress
sar
coronavirusinfect
cell
suggest
viru
evad
antivir
activ
thu
snp
may
probabl
play
import
role
modifi
basal
mxa
express
thu
contribut
significantli
innat
immun
respons
sar
coronaviru
pathogenesi
sar
age
sex
wellknown
confound
factor
sar
individu
age
year
year
associ
lower
risk
proport
women
higher
sar
patient
also
reflect
case
patient
tabl
logist
regress
use
adjust
confound
effect
risk
associ
snp
remain
signific
associ
snp
weaken
tabl
thu
associ
risk
sar
coronaviru
infect
clearli
stronger
snp
despit
proxim
snp
high
genotyp
data
show
allel
correl
low
absenc
haplotyp
sampl
consist
previou
report
show
allel
alway
coexist
allel
never
allel
domin
haplotyp
fact
coexist
indic
ld
snp
complet
given
differ
contribut
snp
nuclearprotein
bind
figur
mxa
promot
activ
depend
whether
prior
stimul
also
clarifi
independ
contribut
snp
associ
sar
coronaviru
infect
previou
associ
studi
mxa
snp
sar
coronaviru
infect
basi
small
sampl
size
inconclus
hamano
et
al
studi
sar
patient
control
subject
vietnam
found
signific
associ
wherea
et
al
chines
han
cohort
sar
patient
control
subject
suggest
heterozyg
genotyp
associ
increas
suscept
sar
anoth
ifninduc
gene
also
studi
small
popul
cohort
g
g
snp
report
associ
sar
coronaviru
infect
largescal
casecontrol
analys
snp
howev
found
signific
associ
tabl
interestingli
confound
effect
snp
significantli
alter
associ
snp
render
associ
snp
insignific
tabl
genet
associ
analysi
probabl
one
largest
casecontrol
cohort
demonstr
first
time
knowledg
signific
associ
genotyp
lower
risk
sar
coronaviru
infect
tabl
appar
associ
becam
insignific
adjust
confound
effect
age
sex
snp
tabl
sar
coronaviru
infect
suppress
endogen
induct
snp
probabl
exert
greater
effect
basal
mxa
express
innat
immun
respons
affect
suscept
sar
import
snp
also
confirm
consist
stronger
associ
snp
affect
adjust
age
sex
genet
background
snp
mxa
reduc
influenza
viral
protein
mice
express
mous
homolog
mxa
shown
protect
highli
lethal
human
influenza
viru
recent
report
show
reduc
delay
product
virusinfect
human
bronchial
epitheli
cell
suggest
attenu
respons
innat
immun
respons
may
contribut
virul
virus
similar
influenza
sar
evas
induct
suggest
snp
may
also
import
suscept
factor
infect
warrant
futur
studi
conclus
show
keep
previous
report
promot
assay
find
allel
mxa
gene
provid
stronger
nuclearprotein
bind
allel
absenc
ifn
stimul
wherea
allel
shown
preferenti
bound
nuclear
protein
extract
ifnstimul
cell
support
vitro
find
larg
genet
associ
studi
provid
vivo
data
confirm
although
snp
demonstr
significantli
decreas
suscept
sar
coronaviru
infect
associ
clearli
stronger
snp
keep
condit
suppress
endogen
ifn
induct
innat
immun
respons
sar
coronaviru
infect
knowledg
differ
contribut
mxa
promot
snp
innat
immun
respons
infect
would
import
assess
one
suscept
infecti
diseas
may
emerg
futur
especi
share
mode
action
similar
sar
coronaviru
